About Pluri
Pluri is a company based in Haifa (Israel) founded in 2003.. The company has 118 employees as of June 30, 2024. Pluri has completed 1 acquisition, including Kokomodo. Pluri offers products and services including 3D Cell Expansion Platform, PLURIHEALTH, PLURIFOOD, PLURICDMO, and PLURIAGTECH. Pluri operates in a competitive market with competitors including Celloid, Mo:re, AIM Biotech, The Well Bioscience and S-BIO, among others.
- Headquarter Haifa, Israel
- Employees 118 as on 30 Jun, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pluri Inc.
-
Annual Revenue
$1.34 M309.82as on Jun 30, 2025
-
Net Profit
$-22.58 M-8.11as on Jun 30, 2025
-
EBITDA
$-21.86 M0.21as on Jun 30, 2025
-
Latest Funding Round
$2.5 M (USD), Post-IPO
Mar 26, 2026
-
Investors
European Union
& 3 more
-
Employee Count
118
as on Jun 30, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Pluri
Pluri is a publicly listed company on the NASDAQ with ticker symbol PLUR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Pluri
Pluri offers a comprehensive portfolio of products and services, including 3D Cell Expansion Platform, PLURIHEALTH, PLURIFOOD, PLURICDMO, and PLURIAGTECH. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for efficient growth of various cell types.
System for medical applications using cell expansion technology.
Technology for producing cultivated meat products.
Virtual platform offering cell-based services.
Platform for cell-based coffee and agricultural innovations.
Unlock access to complete
Funding Insights of Pluri
- Total Funding Total Funding
- Total Rounds 10
- Last Round Post-IPO — $2.5M
-
First Round
First Round
(01 Jan 2017)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2026 | Amount | Post-IPO - Pluri | Valuation |
investors |
|
| Feb, 2025 | Amount | Post-IPO - Pluri | Valuation |
investors |
|
| Jan, 2025 | Amount | Post-IPO - Pluri | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Pluri
Pluri has secured backing from 4 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include European Union, Merchant Adventure Investment Advisors and Alejandro Weinstein. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Offers wealth management, investment advisory, and brokerage services in the U.S.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Pluri
Pluri has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Kokomodo. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cacao production is managed by Kokomodo in Rehovot, Israel.
|
2024 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Pluri
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pluri Comparisons
Competitors of Pluri
Pluri operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celloid, Mo:re, AIM Biotech, The Well Bioscience and S-BIO, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
3D cell culture solutions for drug development are provided.
|
|
| domain | founded_year | HQ Location |
3D cell culture robots are developed for medical research applications.
|
|
| domain | founded_year | HQ Location |
Microfluidic 3D cell culture systems are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Develops xeno-free hydrogels for 3D cell culture and personalized medicine applications.
|
|
| domain | founded_year | HQ Location |
Glycan analysis services and kits are offered by S-BIO.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pluri
Frequently Asked Questions about Pluri
When was Pluri founded?
Pluri was founded in 2003 and raised its 1st funding round 14 years after it was founded.
Where is Pluri located?
Pluri is headquartered in Haifa, Israel. It is registered at Haifa, Haifa District, Israel.
Who is the current CEO of Pluri?
Yaky Yanay is the current CEO of Pluri.
How many employees does Pluri have?
As of Jun 30, 2024, the latest employee count at Pluri is 118.
What is the annual revenue of Pluri?
Annual revenue of Pluri is $1.34M as on Jun 30, 2025.
What does Pluri do?
Founded in 2003 and based in Haifa, Israel, the company focuses on biotechnology through its platform for 3D cell expansion systems. Novel cell-based solutions are advanced for applications in medicine, climate change mitigation, pharmaceuticals, food technology, agriculture technology, and biologics production. Operations emphasize innovation in cell technologies to support diverse sectors.
Who are the top competitors of Pluri?
Pluri's top competitors include Mo:re, Celloid and ExCel Matrix Biological Devices.
What products or services does Pluri offer?
Pluri offers 3D Cell Expansion Platform, PLURIHEALTH, PLURIFOOD, PLURICDMO, and PLURIAGTECH.
Is Pluri publicly traded?
Yes, Pluri is publicly traded on NASDAQ under the ticker symbol PLUR.
How many acquisitions has Pluri made?
Pluri has made 1 acquisition, including Kokomodo.
Who are Pluri's investors?
Pluri has 4 investors. Key investors include European Union, Merchant Adventure Investment Advisors, Alejandro Weinstein, and Alliance Global Partners.
What is Pluri's ticker symbol?
The ticker symbol of Pluri is PLUR on NASDAQ.